138 related articles for article (PubMed ID: 21128935)
1. Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats.
Mizukami H; Ogasawara S; Yamagishi S; Takahashi K; Yagihashi S
Eur J Clin Invest; 2011 Apr; 41(4):442-50. PubMed ID: 21128935
[TBL] [Abstract][Full Text] [Related]
2. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
3. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels.
Jian-bo L; Cheng-ya W; Jia-wei C; Xiao-lu L; Zhen-qing F; Hong-tai M
Nutr Neurosci; 2010 Apr; 13(2):79-86. PubMed ID: 20406575
[TBL] [Abstract][Full Text] [Related]
4. Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve.
Sonobe M; Yasuda H; Hatanaka I; Terada M; Yamashita M; Kikkawa R; Shigeta Y
Horm Metab Res; 1988 Nov; 20(11):717-8. PubMed ID: 3215630
[No Abstract] [Full Text] [Related]
5. Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats.
Cameron NE; Cotter MA; Jack AM; Basso MD; Hohman TC
Diabetologia; 1999 Sep; 42(9):1120-30. PubMed ID: 10447525
[TBL] [Abstract][Full Text] [Related]
6. In vivo effect of methylcobalamin on the peripheral nerve structure in streptozotocin diabetic rats.
Yagihashi S; Tokui A; Kashiwamura H; Takagi S; Imamura K
Horm Metab Res; 1982 Jan; 14(1):10-3. PubMed ID: 6460676
[TBL] [Abstract][Full Text] [Related]
7. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
Cameron NE; Cotter MA
Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
[TBL] [Abstract][Full Text] [Related]
8. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
9. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sharma SS; Sayyed SG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
[TBL] [Abstract][Full Text] [Related]
10. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.
Yamagishi S; Ogasawara S; Mizukami H; Yajima N; Wada R; Sugawara A; Yagihashi S
J Neurochem; 2008 Jan; 104(2):491-9. PubMed ID: 17995925
[TBL] [Abstract][Full Text] [Related]
11. [Survey of current experimental studies of effects of traditional Chinese compound recipe on diabetic peripheral neuropathy].
Wu QL; Liang XC
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):775-8. PubMed ID: 17639971
[TBL] [Abstract][Full Text] [Related]
12. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study.
Obrosova IG; Fathallah L; Lang HJ; Greene DA
Diabetologia; 1999 Oct; 42(10):1187-94. PubMed ID: 10525658
[TBL] [Abstract][Full Text] [Related]
14. Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.
Middlemas A; Delcroix JD; Sayers NM; Tomlinson DR; Fernyhough P
Brain; 2003 Jul; 126(Pt 7):1671-82. PubMed ID: 12805110
[TBL] [Abstract][Full Text] [Related]
15. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy.
Hellweg R; Raivich G; Hartung HD; Hock C; Kreutzberg GW
Exp Neurol; 1994 Nov; 130(1):24-30. PubMed ID: 7821393
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E.
Skalska S; Kyselova Z; Gajdosikova A; Karasu C; Stefek M; Stolc S
Gen Physiol Biophys; 2008 Jun; 27(2):106-14. PubMed ID: 18645225
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment of silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat.
Baluchnejadmojarad T; Roghani M; Khastehkhodaie Z
Phytother Res; 2010 Aug; 24(8):1120-5. PubMed ID: 19960427
[TBL] [Abstract][Full Text] [Related]
18. Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats.
Sasase T; Yamada H; Sakoda K; Imagawa N; Abe T; Ito M; Sagawa S; Tanaka M; Matsushita M
Diabetes Obes Metab; 2005 Sep; 7(5):586-94. PubMed ID: 16050952
[TBL] [Abstract][Full Text] [Related]
19. Diabetic neuropathy and vitamin B12.
Yagihashi S
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():122-5. PubMed ID: 1297721
[No Abstract] [Full Text] [Related]
20. The effects of gliclazide, methylcobalamin, and gliclazide+methylcobalamin combination therapy on diabetic peripheral neuropathy in rats.
Yao H; Feng J; Zheng Q; Wei Y; Wang S; Feng W
Life Sci; 2016 Sep; 161():60-8. PubMed ID: 27496624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
